![]() |
Trials |
A phase Ib/II, multicenter, open-label study to evaluate the efficacy of AUY922 in combination with trastuzumab in patients with locally advanced or metasatatic HER2-positive breast cancer, that has progressed after or during at least one Trastuzumab-conCancer type: Breast cancer Phase: I Principal Investigator: Hatschek Thomas Country: SE Keywords: Sweden, HSP90 inhibitor, HER2 positivity Status: Completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01271920?term=NCT01271920&rank=1 |